EURID
18.8.2020 11:32:11 CEST | Business Wire | Press release
EURid released its Q2 2020 Progress Report today, sharing its quarterly statistics and developments. Highlights include:
- 163 277 new domain name registrations recorded;
- Slovenia tops the list of countries for registration growth at +4.8%;
- The average renewal rate was 83.9%
Total registrations decreased from 3 623 050 at the end of Q1 2020 to 3 606 143 at the end of Q2 2020. This can be attributed to a higher rate of deletions among UK-based registrations in light of the .eu registrations update relating to Brexit.
Main developments throughout the quarter included:
- Kick-off of the 7th annual .eu Web Awards competition;
- Partnership with the Coordination Center for TLD .RU/.РФ for the annual EURid UNESCO World Report on IDNs;
- Strengthening our collaboration with the EUIPO and Ecommerce Foundation to benefit SMEs and .eu online stores;
- Brexit update regarding .eu domain names registered to individuals and undertakings residing in the United Kingdom and Gibraltar: the Withdrawal Agreement between the UK and EU provides a transition period until 31 December 2020 ; as of 1 January 2021, 00:00:00 CET , EURid will no longer allow the registration of any new domain names by UK registrants.
- Supporting the ‘Water is Life’ project in Madagascar to offset our 2019 CO2 emissions.
Read more from EURid’s Q2 2020 Progress Report .
About EURid
EURid is the not-for-profit organisation that operates the .eu, .ею and .ευ top-level domains, following a tender process and appointment by the European Commission. EURid works with over 700 accredited registrars. As part of its ongoing commitment to data security, EURid has been certified for the ISO27001 security standard since 2013. EURid is also registered by the EU Eco-Management and Audit Scheme (EMAS), which is an expression of its environmental commitment. EURid has its headquarters in Diegem (Belgium), and regional offices in Pisa (Italy), Prague (the Czech Republic) and Stockholm (Sweden). More information at: www.eurid.eu.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200818005375/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vecima, Incognito, and BM COM Announce Turnkey Fiber Broadband Solutions at ANGA COM 202613.5.2026 13:30:00 CEST | Press release
Strategic collaboration delivers fully integrated, turnkey fiber broadband solutions that are interoperable and multi-vendor, with no single vendor lock-inJoint “Broadband-in-a-Box” solution combines infrastructure, software, and system integration to accelerate fiber deployments worldwide Vecima Networks Inc., Incognito Software Systems Inc., and BM COM s.r.o., today announced a strategic collaboration to deliver a fully integrated, turnkey fiber broadband solution, which will be showcased at ANGA COM 2026, May 19–21 in Cologne, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513492655/en/ The joint solution brings together best-in-class fiber access infrastructure, advanced service orchestration, and in-market deployment expertise into a unified, interoperable Broadband-in-a-Box platform without requiring single vendor lock-in. Designed to simplify and accelerate fiber broadband rollouts, the solution enables op
Veristat Launches AI Biostatistics Platform, Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days* Without Regulatory Risks13.5.2026 13:05:00 CEST | Press release
InStat™ delivers submission-ready tables, lists and figures (TLF) on validated statistical engines, with Clene Nanomedicine as its first customer Veristat™, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced the launch of InStat™ by Veristat. InStat is the clinical research industry’s first zero-code, fully automated biostatistics solution, reducing manual effort to speed time to approval with every output backed by validated statistical engines and expert biostatistician review. It delivers submission-ready tables, listings, and figures (TLF) in five days or less*, rather than the four to six weeks sponsors typically wait after database lock, while maintaining the highest quality data. Veristat will begin using InStat to deliver biostatistics services in June. Clene Nanomedicine is the first clinical trial sponsor whose work was delivered using InStat, with NfL biomarker analyses supporting their planned 2026 New Drug Application (
Carta Launches Carta Law with Acquisition of Avantia13.5.2026 13:01:00 CEST | Press release
Acquisition marks launch of the largest AI-native law firm for private capital, combining institutional expertise with agent-orchestrated workflows to accelerate fund operations Carta, the agentic enterprise resource planning (ERP) platform for private capital, today announced it has acquired Avantia, a leading AI-powered legal and compliance law firm for asset managers. The acquisition launches Carta Law—the largest AI-native, integrated legal and compliance solution for private markets—unifying legal and compliance workflows with fund operations on a single platform. Private capital firms have long operated with fragmented infrastructure, with fund administration, compliance, and legal services spread across separate vendors. Deal teams wait days for NDAs. Limited partner onboarding to new funds is delayed by KYC backlogs. General counsels lose visibility into legal spend or institutional precedent. As deal velocity increases and regulatory complexity grows, this fragmentation become
Amazfit Unveils the Cheetah 2 Ultra: The Performance Trail Running Watch Built to Master the Toughest Mountain Trails13.5.2026 13:00:00 CEST | Press release
Built for ultra distances and mountain racing, the Cheetah 2 Ultra combines long battery life, precision navigation, and advanced training insights to carry more distance and control more load Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the Cheetah 2 Ultra. Building on the momentum of the recently launched Cheetah 2 Pro—designed for road marathoners—the Ultra is a specialized instrument for trail runners who measure success in elevation, unpredictable terrain, and hours spent on the move. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513230718/en/ Built for ultra distances and mountain racing, the Cheetah 2 Ultra combines long battery life, precision navigation, and advanced training insights to carry more distance and control more load. Amazfit’s Cheetah 2 Ultra is built for runners who prepare for ultra distances and mountain races, boasting 33-hour trail running optimized GPS b
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights13.5.2026 12:30:00 CEST | Press release
FDA granted Compass NDA rolling submission and review request, based on strength of Phase 3 dataCNPV awarded for COMP360 in TRD, further accelerating momentum26-week (Part B) data from COMP006, expected in early Q3 2026Final NDA submission on track for Q4, aligned with Company’s previously defined accelerated timing to be launch ready by end of yearSuccessful financing and warrant exercises resulted in strong cash position of $466 million at end of first quarter, providing cash runway well beyond launch and into 2028 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported first quarter 2026 financial results and business highlights. “With regulatory acceleration unfolding, we are working diligently towards our goal of completing the filing of a robust clinical package by Q4 and securing COMP360 approval,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “COMP360 repr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom